Kayvon J. Paul

Kayvon’s corporate practice involves advising life sciences companies on a broad range of M&A and securities matters, including 33' and 34' Act reporting, Nasdaq and NYSE-related matters, capital market offerings (e.g., ATMs, RDOs, CMPOs, PIPEs), reverse stock splits, and general corporate governance. Kayvon has experience in reviewing and preparing SEC disclosures (e.g., Form 8-K, Form 10-Q, Form 10-K, Proxy Statements) and registration statements, board and committee resolutions, corporate governance presentations, and press releases. Kayvon also regularly advises senior executives and boards of directors, on securities, governance, transactional, and a range of other complex issues.

Kayvon’s pro bono practice involves preparing business formation documents, commercial agreements, and corporate policies for underrepresented entrepreneurs. Kayvon also works with the Homeless Advocacy Project to help housing insecure individuals apply for social security disability benefits.

During law school, Kayvon completed the U.S. Securities and Exchange Commission's honors program where he investigated insider trading schemes involving clinical-stage drug companies, and Ponzi schemes involving digital assets and real estate. Kayvon served as an extern for the Honorable Michael A. Shipp (D.N.J.) where he helped draft a securities opinion on a matter of first impression. Before finishing law school, Kayvon published two law review articles, including an article on digital market manipulation.

Before law school, Kayvon was a lobbyist for a reputable New Jersey government affairs firm, where he represented clients in healthcare, renewable energy, and cannabis industries on regulatory and legislative issues before the Governor’s Office and the New Jersey State Legislature.